Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Smolen

Showing results (171-180 of 1,725) with videos related to

Pageof 173
Sort By:
Proceedings of the Institution of Mechanical Engineers. Part H, Journal of Engineering in Medicine|October 4, 2016
The effect of ankle posture on the load pathway through the hindfootChris Smolen, Cheryl E Quenneville
Rheumatology (Oxford, England)|June 22, 2012
Future of RA: building on what we know and tailoring treatmentJosef Smolen, Edward C Keystone
Nature Reviews. Rheumatology|February 18, 2015
Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challengesJosef S Smolen, Daniel Aletaha
Annals of the Rheumatic Diseases|November 9, 2012
Forget personalised medicine and focus on abating disease activityJosef S Smolen, Daniel Aletaha
The Journal of Rheumatology|August 16, 2002
Effectiveness profiles and dose dependent retention of traditional disease modifying antirheumatic drugs for rheumatoid arthritis. An observational studyDaniel Aletaha, Josef S Smolen
Nature Clinical Practice. Rheumatology|August 26, 2006
Is adalimumab in combination with methotrexate a safe and efficacious treatment for early rheumatoid arthritis?Josef S Smolen, Daniel Aletaha
Arthritis Research & Therapy|June 1, 2011
Infliximab: 12 years of experienceJosef S Smolen, Paul Emery
Autoimmunity Reviews|May 31, 2011
Therapeutic blockade of TNF in patients with SLE-promising or crazy?Martin Aringer, Josef S Smolen
Arthritis and Rheumatism|January 5, 2011
Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: the role of acute-phase reactantsJosef S Smolen, Daniel Aletaha
Best Practice & Research. Clinical Rheumatology|January 24, 2012
Diseases of the musculosketelal system. PrefaceDick Heinegård, Josef S Smolen
Pageof 173

Showing results (171-180 of 1,725) with videos related to

Sort By:
Pageof 173
Proceedings of the Institution of Mechanical Engineers. Part H, Journal of Engineering in Medicine|October 4, 2016
The effect of ankle posture on the load pathway through the hindfootChris Smolen, Cheryl E Quenneville
Rheumatology (Oxford, England)|June 22, 2012
Future of RA: building on what we know and tailoring treatmentJosef Smolen, Edward C Keystone
Nature Reviews. Rheumatology|February 18, 2015
Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challengesJosef S Smolen, Daniel Aletaha
Annals of the Rheumatic Diseases|November 9, 2012
Forget personalised medicine and focus on abating disease activityJosef S Smolen, Daniel Aletaha
The Journal of Rheumatology|August 16, 2002
Effectiveness profiles and dose dependent retention of traditional disease modifying antirheumatic drugs for rheumatoid arthritis. An observational studyDaniel Aletaha, Josef S Smolen
Nature Clinical Practice. Rheumatology|August 26, 2006
Is adalimumab in combination with methotrexate a safe and efficacious treatment for early rheumatoid arthritis?Josef S Smolen, Daniel Aletaha
Arthritis Research & Therapy|June 1, 2011
Infliximab: 12 years of experienceJosef S Smolen, Paul Emery
Autoimmunity Reviews|May 31, 2011
Therapeutic blockade of TNF in patients with SLE-promising or crazy?Martin Aringer, Josef S Smolen
Arthritis and Rheumatism|January 5, 2011
Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: the role of acute-phase reactantsJosef S Smolen, Daniel Aletaha
Best Practice & Research. Clinical Rheumatology|January 24, 2012
Diseases of the musculosketelal system. PrefaceDick Heinegård, Josef S Smolen
Pageof 173